NICE is currently updating its clinical guideline on Intrapartum Care (CG55) and the progress of the update can be monitored via their website. They will consult on the draft recommendations with stakeholders between 13th May - 24th June 2014 and the final guideline will be published in October 2014. (AI summary)
View full response
NICE National Institute for 10 Spring Gardens Health and Care Excellence London SWIA 2BU United Kingdom +44 (0)845 003 7780 pathological, oxytocin should be stopped and a full assessment of the fetal condition undertaken by an obstetrician before oxytocin is recommenced_ The definition of suspicious and pathological is set out in the NICE clinical guideline (CG55). The NICE clinical guideline on Intrapartum Care (CG55) also states, that the maternal pulse should be palpated, on initial assessment in labour and during labour; if there is suspected fetal braycardia or any other fetal heart rate anomaly; to differentiate between maternal and fetal heart rate We review all of our guidance at regular intervals and also consider feedback and requests for updates where this is appropriate_ Our clinical guideline on Intrapartum Care (CG55) is currently being updated: The progress of the update can be monitored via our website (http Ilguidance nice org:ukICGWaveR/109): The team working on updating this guideline re-examined the evidence on fetal assessment and monitoring during labour: This specifically includes cardiotocography on admission to the labour ward and during labour and the definition and interpretation of the features of fetal heart rate trace. Whilst | am not able to anticipate the outcome of the final guideline, can report that we have found no evidence to support a significant change in the recommendations but have been further strengthened where appropriate. We will consult on the draft recommendations with stakeholders between 13th May 24th June 2014 and the final guideline will be published in October 2014. We have confidence that our guidance, correctly implemented, will provide the best outcomes for patients but clinicians retain the responsibility for their decisions. NICE Clinical Guidelines are not mandated and clinical staff can depart from them if there are appropriate and documented clinical reasons for doing so. With kind regards, Programme Director, Centre for Clinical Practice have they